In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-22

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose with this clinical investigation is to perform Raman spectroscopy inside the vivid bladder and to acquire Raman spectra of normal and tumour bladder tissue, and in a post-processing step to determine the grade of the tumor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

NCT06087016

Urinary Bladder Tumour

RECRUITING

Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy

NCT04943094

Non-muscle Invasive Bladder Cancer

ACTIVE_NOT_RECRUITING

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

NCT00244205

Bladder Cancer

UNKNOWN

Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment

NCT05273593

Bladder Cancer CLE

COMPLETED NA

Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study

NCT04194112

Bladder Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose with this clinical investigation is to perform Raman spectroscopy inside the vivid bladder and to acquire Raman spectra of normal and tumour bladder tissue, and in a post-processing step to determine the grade of the bladder tumor.

The recordings and overall results will be compared to standard histo/cytopathological examination of urological tissue to achieve a clinical useful concordance between gold standard histo/cytopathological diagnosis and diagnostic information established by Raman.

The MIB RAMAN SYSTEM in combination with a Raman probe will be used in the operating theatre at Herlev/Copenhagen hospital urology department, where the rigid resectoscopes will be used while the trial participant is under general anesthesia. Each measurement takes about 1-5 seconds and the whole procedure with the fiber optic probes is expected to prolong the operation with 10-15 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endoscopic Bladder Cancer Diagnosis With Raman

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Tumor identified during endoscopy of the bladder is examined with Raman spectrometry. Tumor is resected. Histopathological diagnosis is compared with results of Raman spectrometry.

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Patient tumor stage is unknown for the examiner.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diagnostic ability of Raman spectrometry

Endoscopic Raman spectrometry during endoscopic bladder cancer surgery

Group Type EXPERIMENTAL

Raman Spectrometry

Intervention Type DIAGNOSTIC_TEST

Bladder tumor is examined with Raman spectrometry during endoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Raman Spectrometry

Bladder tumor is examined with Raman spectrometry during endoscopy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

After booking for surgery the trial participants will be informed orally about the study and written material will be given by a doctor or nurse form the study group. If the trial participant accept to enter the study, written informed consent will be obtained. The trial participant will be informed that they can withdraw the informed consent at any time and the treatment will be according to the guidelines of the department.

Exclusion Criteria

* Macroscopic hematuria
* Pregnant or breast-feeding women
* Expected poor compliance
* Persons \< 18 years
* Persons who do not read or understand Danish
* Dementia

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No